Clinical Experience of Personalized Phage Therapy Against Carbapenem-Resistant Acinetobacter baumannii Lung Infection in a Patient With Chronic Obstructive Pulmonary Disease
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical Experience of Personalized Phage Therapy Against Carbapenem-Resistant Acinetobacter baumannii Lung Infection in a Patient With Chronic Obstructive Pulmonary Disease
Authors
Keywords
-
Journal
Frontiers in Cellular and Infection Microbiology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-02-26
DOI
10.3389/fcimb.2021.631585
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Bacteriophage-resistant Acinetobacter baumannii are resensitized to antimicrobials
- (2021) Fernando Gordillo Altamirano et al. Nature Microbiology
- Characterization and genomic analysis of ValSw3-3, a new Siphoviridae bacteriophage infecting Vibrio alginolyticus
- (2020) Ling Chen et al. JOURNAL OF VIROLOGY
- Phage Therapy in the Postantibiotic Era
- (2019) Fernando L. Gordillo Altamirano et al. CLINICAL MICROBIOLOGY REVIEWS
- Phage Therapy: A Renewed Approach to Combat Antibiotic-Resistant Bacteria
- (2019) Kaitlyn E. Kortright et al. Cell Host & Microbe
- Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus
- (2019) Rebekah M. Dedrick et al. NATURE MEDICINE
- Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis
- (2018) Evelina Tacconelli et al. LANCET INFECTIOUS DISEASES
- Resistance Development to Bacteriophages Occurring during Bacteriophage Therapy
- (2018) Frank Oechslin Viruses-Basel
- In Vitro Design and Evaluation of Phage Cocktails Against Aeromonas salmonicida
- (2018) Ling Chen et al. Frontiers in Microbiology
- Phage Therapy for a Multidrug-Resistant Acinetobacter baumannii Craniectomy Site Infection
- (2018) Stephanie LaVergne et al. Open Forum Infectious Diseases
- Nephrotoxicity of Polymyxins: Is There Any Difference between Colistimethate and Polymyxin B?
- (2016) Alexandre P. Zavascki et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges
- (2016) Darren Wong et al. CLINICAL MICROBIOLOGY REVIEWS
- Phage on tap–a quick and efficient protocol for the preparation of bacteriophage laboratory stocks
- (2016) Natasha Bonilla et al. PeerJ
- Characterization of the inflammatory response to inhaled lipopolysaccharide in mild to moderate chronic obstructive pulmonary disease
- (2015) Vandana Gupta et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Chromosomal DNA deletion confers phage resistance to Pseudomonas aeruginosa
- (2014) Shuai Le et al. Scientific Reports
- Randomized Phase 2 Trial To Evaluate the Clinical Efficacy of Two High-Dosage Tigecycline Regimens versus Imipenem-Cilastatin for Treatment of Hospital-Acquired Pneumonia
- (2013) Julio Ramirez et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- SOAPdenovo2: an empirically improved memory-efficient short-read de novo assembler
- (2012) Ruibang Luo et al. GigaScience
- The RAST Server: Rapid Annotations using Subsystems Technology
- (2008) Ramy K Aziz et al. BMC GENOMICS
- Antimicrobial Resistance:Acinetobacter baumannii:Epidemiology, Antimicrobial Resistance, and Treatment Options
- (2008) Lisa L. Maragakis et al. CLINICAL INFECTIOUS DISEASES
- The CGView Server: a comparative genomics tool for circular genomes
- (2008) J. R. Grant et al. NUCLEIC ACIDS RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now